BioExx Files for Fourth Patent

    TORONTO, Sept. 11 /CNW/ - Bio-Extraction Inc. (TSX-V: BXI) ("BioExx")
( is pleased to announce that it has filed a patent
application, and now has a patent pending, for its design of a Continuous
Counter Flow ("CCF") bio-extraction facility and corresponding process. The
technology represented by this innovation will play a key role in BioExx's
pending commercial engagement of the massive global oilseeds (and bio-diesel)
    Traditionally, a methodology known as Continuous Counter Current ("CCC")
has been used as the baseline design for very large scale extraction
facilities that utilize conventional solvents, such as hexane. These legacy
CCC facilities have therefore been designed for alignment with the properties
of conventional higher-temperature operating solvents. Since the BioExx value
proposition uniquely leverages the protein-retentive and compound-sensitive
properties of its patented low-temperature extraction solvents, a novel
process solution was required. This is the basis for the newly filed BioExx
patent application, which BioExx calls Continuous Counter Flow ("CCF").
    "With this patent application filing, we are extending the breadth of our
proprietary technology from being solvent-based to now also being
process-based. This extends our technology advantage directly into an economic
advantage versus conventional extraction facilities, at any volume or scale,
and allows us to immediately and aggressively enter major oilseed extraction
markets, including bio-diesel." said Chris Carl, founder and President of
BioExx. "While there are of course many applications that work well with the
existing BioExx Continuous Batch process, our move to CCF will allow
significant acceleration of our construction plans and will be applicable in
our first full-scale commercial extraction facility."
    The design and patent was completed through the hard work of the entire
BioExx management team and through data accumulated at the BioExx R&D
facilities in Charlottetown, PEI.
    The patent application has been filed in the United States. BioExx
intends to use this filing as a basis for future patent applications in all of
its targeted major global markets.

    About Bio-Extraction Inc.

    BioExx is involved in the development and commercialization of extraction
technology, which it intends to use to extract various active ingredients from
organic and inorganic materials. Global in scope, the BioExx target markets
include extractions in food oils and fixed oils (including bio-fuels),
nutraceutical, pharmaceutical, and industrial cleansing (eg. specialty
steels). Compared to traditional technologies, the patented BioExx technology
can provide the benefits of lower extraction costs, higher quality extracted
ingredients, and material incremental revenue opportunities as its extractions
can substantially retain the value of inherent proteins and other sensitive
compounds - with all this being completed in an environmentally responsible
    To find out more about Bio-Extraction Inc. (TSX-V: BXI), please visit our
website at

    The statements made in this Press Release may contain forward-looking
statements that may involve a number of risks and uncertainties. Actual events
or results could differ materially from the Company's expectations and
projections. The TSX Venture Exchange has not reviewed this press release and
neither approved nor disapproved the information contained in this press

For further information:

For further information: Chris Schnarr, Chief Financial Officer, BioExx,
(416) 588-4442, x.111,; Investor Relations: Scott Koyich,
President, Brisco Capital Partners, (403) 262-9888,;
or Gordon Aldcorn, (403) 262-9888,; or On the
internet at AGORACOM Investor Relations,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890